Peptide transporters of the PepT family have key roles in the transport of di-and tripeptides across membranes as well as in the absorption of orally administered drugs in the small intestine. We have determined structures of a PepT transporter from Shewanella oneidensis (PepT So2 ) in complex with three different peptides. The peptides bind in a large cavity lined by residues that are highly conserved in human PepT1 and PepT2. The bound peptides adopt extended conformations with their N termini clamped into a conserved polar pocket. A positively charged patch allows differential interactions with the C-terminal carboxylates of di-and tripeptides. Here we identify three pockets for peptide side chain interactions, and our binding studies define differential roles of these pockets for the recognition of different subtypes of peptide side chains.
a r t i c l e s
Many proton-coupled secondary active transporters of the major facilitator superfamily (MFS) are involved in the accumulation of nutrients above extracellular levels 1, 2 . Structural and functional studies of MFS transporters suggest an alternating-access mechanism for substrate transport across the membrane [3] [4] [5] . Here, the transporter adopts different conformational states, allowing the substrate-binding site to face either side of the membrane. A full transport cycle involves at least three different conformational states (inward open, occluded and outward open), with each of them able to adopt a ligand-bound and ligand-free state. Proton-coupled oligopeptide transporters of the PepT family (also known as the POT family) are responsible for the uptake of a broad range of different di-and tripeptides derived from the digestion of dietary proteins [6] [7] [8] . The family is highly conserved in all kingdoms of life, and the best-studied members include the two human peptide transporters PepT1 and PepT2. PepT1 and PepT2 are of major pharmacological importance because they also transport a number of drugs and amino acid-conjugated prodrugs across cellular membranes 9, 10 , besides mediating uptake of short-chain peptides. A detailed understanding of the structural basis for substrate recognition could therefore help facilitate conversion of pharmacologically active compounds into substrates for PepT1 and PepT2 and thus improve the compounds' bioavailability and distribution in the body 11 . To our knowledge, there are currently no high-resolution structures available for either of the human PepT transporters, but four bacterial homologs have been reported: PepT So from S. oneidensis in occluded conformation 12 ; PepT St from Streptococcus thermophilus in inward-open form 13 ; and PepT So2 from S. oneidensis 14 and GkPOT from Geobacillus kaustophilus 15 , both as inward-open structures crystallized in the presence of the antibacterial compound alafosfalin. However, structural information on peptide binding to PepT transporters has so far been lacking, and this has severely limited the potential of the current structures to aid in drug development.
RESULTS
To shed light on the structural basis for the promiscuous substrate recognition of PepT transporters, we determined the structures of PepT So2 cocrystallized with three different peptides: Ala-Ala-Ala, Ala-Tyr(l-3,5-di-Br) and Ala-Tyr(l-3,5-di-Br)-Ala (henceforth referred to as AAA, AY(Br) and AY(Br)A, respectively). The transporter was expressed, purified and crystallized as described previously 14, 16 . Diffraction data were anisotropic; therefore, we carried out ellipsoidal truncation and scaling in order to improve the maps. The resulting electron density maps were of sufficient quality to identify and model the respective ligands and protein side chains ( Fig. 1 and Supplementary Figs. 1 and 2) . The main chain dihedral angles of the three peptide substrates could, however, not be unambiguously established at the present resolution. The correct placement of the two Tyr(l-3,5-di-Br)-containing peptides was confirmed by strong anomalous densities for the bromine atoms (Fig. 1) . We refined the resulting structures at maximal resolutions of 3.2 Å, 3.2 Å and 3.9 Å, respectively ( Table 1 and Online Methods).
PepT So2 comprises 14 transmembrane helices (H), with H1-H6 and H7-H12 constituting the N-and C-terminal six-helical bundles characteristic of the MFS fold. HA and HB correspond to the two transmembrane helices that are generally found to be inserted in the linker connecting the two bundles in prokaryotic PepT transporters. The PepT So2 structures are in the inward-open conformation, in which a large central crevice hosting the substrate peptides is facing the intracellular side of the membrane (Supplementary Fig. 3 ). The overall structures of the three refined peptide-bound PepT So2 complexes are very similar to each other except for some variation in the C-terminal bundle including H10 and H11 (ref. 14 and Supplementary Fig. 4) .
The peptide-binding site overlaps with the binding site previously identified for the antibacterial compound alafosfalin 14 ( Supplementary Fig. 4 ). In the AY(Br) structure, modeling of the a r t i c l e s tyrosine side chain could be guided by anomalous densities for the two cis-bromide moieties originally present in the peptide, whereas in the tripeptide AY(Br)A only one bromide was visible in the anomalous map (Fig. 1a,c) . Elimination of one bromine atom was supported by the strong negative F o − F c density for bromine when we used a double-brominated peptide in refinement ( Supplementary  Fig. 1d ), consistently with the relative lability of bromine-phenol analogs 17, 18 . F o − F c density for main chain moieties was present in all three peptides (Supplementary Fig. 1 ). Furthermore, in the AY(Br) and AY(Br)A structures the substrate F o − F c difference density was present in only one of the two monomers, thus resulting in artificially higher B values because of the averaging effect of the phase information.
A striking feature was the similar binding mode for the substrate backbones, suggesting defined regions for harboring different side chain groups in the binding site. At their N termini, the peptides were clamped down in a polar region formed by Glu402, Asn151, Asn329 and Tyr147 (Fig. 1d) , all of which are conserved in mammalian PepT1 and PepT2 ( Fig. 1 and Supplementary Table 1) . Tyr29, also conserved in the mammalian homologs, has a key role in establishing hydrogen bonds with the main chain moieties of peptide position 1 and 2. The exact hydrogen-bonding patterns with the main chain groups could, however, not be unambiguously established at the present resolution.
At their C termini, the peptides extend into a positively charged patch formed by Arg25 and Lys121, both of which are highly conserved in the PepT family ( Fig. 1d and Supplementary Table 1) . The peptides, however, do this differently; the carboxylate of the dipeptide AY(Br) interacts primarily with Arg25, whereas the carboxylates of the two tripeptides AY(Br)A and AAA extend further down in the pocket, in slightly divergent directions but with both positioned to interact with Lys121. Arg25 and Lys121 might therefore have different roles in recognition of di-and tripeptides (Fig. 1d) .
For a more comprehensive description of the substrate-protein interaction, we divided the PepT So2 binding site into three pockets (P1-P3), with peptide side chain 1 residing in pocket 1. The alanine side chain in position 1 extends down into a small pocket formed by Ser154, Tyr29, Met158 and Pro330, denoted the P1 pocket (Fig. 2) . This pocket is likely to accommodate only small-to medium-sized residues and would not be suitable for aromatic or large charged side chains. 
r t i c l e s
The tyrosine side chain in position 2 of the peptides AY(Br) and AY(Br)A resides in the P2 site, denoted the P2 pocket, which was dominated by the hydrophobic residues Phe287, Phe288 and Tyr291 of helix 7 (Fig. 2) . However, the side chain of Ser406 could potentially also provide polar interactions to peptide side chains. This pocket was larger than P1 and is likely to accommodate large aromatic or polar side chains.
The alanine side chain in position 3 points into the P3 pocket formed by Tyr28, Trp54, Ala58, Ile61, Gln292 and Gln437 (Fig. 2) . This pocket seems to be well suited for harboring a range of different medium-and large-sized peptide side chains. All three pockets are expected to have a similar character in the mammalian PepT homologs because the majority of the residues are conserved ( Supplementary  Fig. 3 and Supplementary Table 1) .
A well-known feature of the members of the POT family is their promiscuous substrate specificity 2, 19 . In order to obtain a better understanding of the side chain preferences of PepT So2 substrates, we performed uptake experiments in proteoliposomes. We reconstituted PepT So2 into liposomes and incubated them with radioactive labeled dipeptide l-[ 3 H]Ala-Ala in the presence of ten-fold competing tripeptides. The tripeptides were designed in a way that allowed us to systematically explore each peptide position. The basic scaffold was an AYA peptide. Thus, to explore pockets 1, 2 or 3, we varied Ala1, Tyr2 or Ala3, respectively. In parallel, we measured the biophysical interactions of these peptides with purified PepT So2 , using a thermal shift assay. Peptides substantially stabilizing the transporter against thermal unfolding typically also had a strong inhibition effect on the uptake of the radioactive dipeptide in the transport assay. However, larger hydrophobic residues in positions 1 and 2 were somewhat disfavored in the liposome transport assay in comparison to the thermal shift assay (Fig. 3, Supplementary Fig. 5 and Supplementary Table 2 ).
DISCUSSION
The results from these studies confirmed our previous data regarding the preference for di-and trialanine over a single alanine amino acid 14 . We furthermore observed that small-and medium-sized hydrophobic and aromatic side chains are, in general, well accommodated in all three positions of the peptide, in accordance with the largely hydrophobic nature of the binding-site pockets (Fig. 2) . More specifically, we found for position 1 that valine, cysteine and methionine showed the strongest stabilization effect, whereas glycine or negatively charged glutamate in this position neither stabilized the protein nor inhibited uptake of radioactive l-[ 3 H]Ala-Ala. In position 2, the strongest inhibition was present for arginine, methionine and leucine followed by glutamine, serine and histidine. In position 3, methionine and tyrosine were preferred, whereas glycine and positively charged side chains were strongly disfavored. The latter was consistent with an unfavorable charge effect of the positively charged patch formed by Lys121 and Arg25. Notably, our tripeptide binding a r t i c l e s data suggested that glycine residues were highly unfavorable in both positions 1 and 3 of tripeptides. (We did not test position 2.) This is concordant with the fact that besides side chain recognition, specific main chain conformations are a key determinant for peptide binding, consistently with the high conservation of residues involved in interactions with the peptide main chain moieties within the PepT family. This was also supported by a dipeptide binding study of the yeast transporter Ptr2p 20 , in which both glycine and proline were found to be highly disfavored in both positions of the peptide. Indeed, despite the lack of larger side chains, the trialanine peptide shows similar inhibition efficiency in the uptake assay as that of peptides with larger hydrophobic residues, thus suggesting that a large part of the affinity is accomplished by the conserved backbone interactions. Despite the moderate sequence identity of 20% between PepT So2 and its human homologs PEPT1 and PEPT2, the substratebinding residues are highly conserved (Supplementary Fig. 3 and Supplementary Table 1) . It is therefore likely that the substrate binding mode revealed in the present study reflects the principles for how broad substrate specificity is accomplished in the human homologs. The current study suggests that the principal recognition mode of the peptide backbone might be highly conserved in the PepT family. The peptide backbone is also likely to occupy the same binding site in the human homologs as that described in this study. Here, we have identified a number of hydrophobic and tyrosine-containing patches, complemented by potential polar interaction partners, as important determinants for the recognition of peptide side chains (pockets 1-3). Furthermore, conformational changes of aromatic clusters allow the modulation of the binding site, and this could extend the spectra of possible substrates. Pharmacophores for drug binding and transport suggest that an amino group and a central polar unit are advantageous for binding and transport, whereas a carboxylate group is optional 10 . Transported drugs typically also contain a central aromatic framework. A possible binding mode of these drugs, in agreement with the present structures, is the accommodation of the amino group in the same site as the peptide N termini, whereas the rest of the drug extends in to P2 and P3. When a carboxylate group is present, a potential interaction with the positively charged patch (Arg25 and Lys121) could be formed. Some successful prodrugs have been generated by linking the pharmaceutically active drugs to the carboxylate groups of small amino acids (alanine and valine) [9] [10] [11] . It is plausible that these small amino acids reside in the P1 pocket, allowing the rest of the drug to extend into the larger P2 and P3 pockets. Indeed we have shown that alanine and valine are strongly favored in P1.
This work together with further structural studies of drug-bound forms of PepT family proteins is likely to have a substantial impact on the rational design of prodrugs and drugs with improved absorption and distribution properties.
METHODS
Methods and any associated references are available in the online version of the paper. 
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ONLINE METHODS
Structure determination. Expression and purification of PepT So2 was performed as recently described 21 . Peptides were purchased from Genscript and GL Biochem. Prior to crystallization, PepT So2 was incubated with 10 mM of various peptides for 30 min at 4 °C. 3% of the additive trimethylamine N-oxide dehydrate, pH 11, was added to the crystallization screen for all complexes. Crystals were obtained by vapor diffusion at 20 °C in 0.1 M phosphate citrate (pH 4.5 for AAA and pH 4.0 for AY(Br)A and AY(Br); 36-46% PEG 300 and 0.12 M ZnCl 2 ). The AAA data set was collected at BESSY MX 14.3, and AY(Br)A and AY(Br) data sets were both collected at Diamond light source, beamline I03. The data were processed with XDS and XSCALE, and the space group was P2 1 2 1 2 1 with two molecules in the asymmetric unit. The solvent content was 68.04%, 70.18% and 68.81% for AAA, AY(Br)A and AY(Br), respectively. Owing to the anisotropic X-ray diffraction of the crystals, ellipsoidal truncation was carried out by the diffraction anisotropy server 22 . For final resolution limits along the a, b and c axes, we used 3.7, 3.2 and 3.2 Å for the AAA data; 4.0, 3.8 and 4.0 Å for the AY(Br)A data; and 4.0, 3.2 and 3.2 Å for the AY(Br) data. These limits were chosen on the basis of the F/σ-versus-resolution plot generated by the anisotropy server and the outer-shell I/σI values.
Phases were obtained by molecular replacement with the previously determined PepT So2 structure (PDB 4LEP) as a search model. Real-space building was performed in Coot 23 . Model refinement and omit maps were made in auto-BUSTER (http://www.globalphasing.com/buster/) and PHENIX 24 . Translation libration screw (TLS) and noncrystallographic symmetry (NCS) restraints were used in all refinements. Refinement statistics are shown in Table 1 , and electron density maps are shown in Figure 1 and Supplementary Figures 1 and 2 . The models were validated with MolProbity 25 , and figures were generated in PyMOL (http://www.pymol.org/). For the AAA structure, there were 92.59% favored and 1.48% outliers in the Ramachandran plot. The clash score was 14.66 (97th percentile), and the overall score was 2.44 (97th percentile for structures at 3.20 ± 0.25 Å). For the AY(Br)A structure, there were 93.10% favored and 1.3% outliers in the Ramachandran plot. The clash score was 7.91 (97th percentile for structures at 3.00-9,999 Å), and the overall score was 2.00 (100th percentile). For the AY(Br) structure, there were 89.62% favored and 1.69% outliers in the Ramachandran plot. The clash score was 19.04 (95th percentile for structures at 2.91-9,999 Å), and the overall score was 2.90 (87th percentile for structures at 3.16 ± 0.25 Å).
Stargazer thermal aggregation assay. Temperature-dependent aggregation (T agg ) was measured with a StarGazer-384 plate reader (Harbinger Biotechnology and Engineering Corporation) in a buffer consisting of 20 mM Na-P, pH 7.5, 150 mM NaCl, 5% glycerol, 0.5 mM TCEP and 0.03% DDM. The amount of aggregated PepT So2 was analyzed as a function of increasing temperature in the presence of various tripeptides (Supplementary Fig. 5 ). 0.3 mg/ml PepT So2 (total sample volume 50 µl) was incubated together with 5 mM tripeptides for 20 min shaking at 4 °C. Prior to analysis, the protein samples were centrifuged for 5 min at 14,000g and dispensed into a clear-bottom 384-well plate (Nunc). The heating rate was set to 1 °C/min from 25 to 80 °C. Light scattering from aggregated proteins was detected from the top of the plate with a CCD camera (QIMAGING 12-bit). To determine the aggregation temperature (T agg ), the observed scattering intensities were plotted against the temperature and fit to the Boltzmann equation by nonlinear regression.
PepT So2 reconstitution into liposomes. Acetone-stored Escherichia coli polar lipids (Avanti) were dried under a constant stream of nitrogen and resuspended in buffer containing 100 mM KP i , pH 7.5, 2 mM β-mercaptoethanol, and 1.5% β-d-octylglucoside at a concentration of 20 mg/mL. Detergent was removed by dialysis against 100 mM KP i , pH 7.5, and 2 mM β-mercaptoethanol. Subsequently the lipids were stored at −80 °C until further use. PepT So2 proteoliposomes were produced with adapted reconstitution protocols of the proline transporter PutP and the lactose transporter LacS 26, 27 . For reconstitution, lipids were thawed at room temperature, extruded with a 400-nm filter and diluted to a lipid concentration of 5 mg/mL. Thereupon, 0.12% Triton X-100 was added and mixed for 10 min. Subsequently, purified PepT So2 was added to the destabilized liposomes at a protein/lipid ratio of 1:100 (w/w) and mixed for another 10 min. For detergent removal, Bio-Beads SM-2 were added (bead/DDM ratio of 1:10 (w/w) and bead/Triton X-100 ratio of 1:5 (w/w)), and the suspension was incubated under gentle agitation for 1 h at room temperature. This step was repeated once, and for complete detergent removal twice the amount of fresh beads was added and the suspension incubated in a cold room overnight. The next day, Bio-Beads were removed, and the proteoliposomes were dialyzed three times against 100 mM KPi, pH 7.5, and 2 mM β-mercaptoethanol, collected by ultracentrifugation for 1 h at 300,000g at 4 °C and stored at −80 °C until further use.
l-alanyl-l-alanine (l-[ 3 H]Ala-Ala) uptake assays. For uptake experiments, proteoliposomes were thawed, diluted in buffer containing 100 mM KPi, pH 7.5, 2 mM β-mercaptoethanol and 5 mM MgCl 2 at room temperature, extruded through a 400-nm filter and collected by ultracentrifugation for 1 h at 300,000g at 25 °C. The final PepT So2 concentration in the proteoliposome suspension was approximately 100 µM, as determined by a modified Lowry assay 28 . To start the uptake reaction, proteoliposomes were diluted 400-fold into assay buffer (100 mM Tris, MES, pH 6.0, 5 mM MgCl 2 , 2 mM β-mercaptoethanol and 0.2 µM valinomycin). PepT So2 -mediated l-Ala-Ala uptake was stopped by addition of ice-cold K + /Li + stop buffer (100 mM KPi, pH 6.6, and 100 mM LiCl) and subsequent immediate filtration through 0.22-µm nitrocellulose filters (Millipore). The amount of substrate imported into the proteoliposomes was determined by scintillation counting and was converted into moles according to an l-[ 3 H]Ala-Ala standard. Data were plotted and analyzed with Graph Pad Prism 6.01, with appropriate algorithms.
For initial characterization of the transport properties of PepT So2 , timedependent proton-driven l-[ 3 H]Ala-Ala was measured by addition of 25 µM l-[ 3 H]Ala-Ala adjusted to a specific radioactivity of 80 mCi/mmol. Uptake was stopped after different incubation times (0, 0.17, 0.5, 1, 2, 5, 10 and 30 min). Equally treated, protein-free liposomes were used as negative control. The initial rate of transport was calculated from the initial linear portion of the time course. To determine the affinity of PepT So2 for l-[ 3 H]Ala-Ala, the initial rates of transport were measured at increasing substrate concentrations (0 to 500 µM), and the data were fit to a standard Michaelis-Menten equation. To evaluate the properties of the proposed three different binding pockets, competition experiments were performed. l-[ 3 H]Ala-Ala was used as tracer at a concentration of 25 µM, which was supplemented with 250 µM of the respective tripeptides. Subsequently, the initial rates of transport were determined, and inhibition of l-[ 3 H]Ala-Ala uptake relative to uninhibited wild-type activity was calculated.
